At first glance, CVS appeared to do everything right. The company delivered better-than-expected quarterly results and reaffirmed much of its outlook, yet the stock sold off sharply as investors focused on future margin pressures and the company’s longer-term outlook rather than the quarter that had just been reported. It’s a good reminder that Wall Street doesn’t simply reward good earnings—it rewards companies that exceed already-high expectations and provide confidence about what’s ahead.

Technically, the chart took a meaningful hit. Price broke below both the 8-day and 21-day exponential moving averages, signaling a loss of short-term momentum. The PPO has crossed lower with an expanding negative histogram, suggesting bearish momentum is building, while the Relative Rotation Graph (RRG) has slipped below the 100 level, indicating CVS is beginning to underperform the broader market. The ADX also shows sellers taking control, with the -DI well above the +DI. While the stock may be due for a short-term bounce after today’s decline, any rally back toward the 8- or 21-day EMA that fails could provide a more favorable entry for traders looking at put opportunities.

Wishing you the best,

Wendy

Advertisement - A $15k trading account can potentially provide greater security than a 7-figure bank account! Click Here to learn more